CervoMed Inc. (CRVO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 71.43M |
| Enterprise Value | 63.19M |
| P/E Ratio | -0.82 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 75.2 |
| Price/Book Ratio | 1.17 |
| Enterprise/Revenue | 5.57 |
| Enterprise/EBITDA | -0.06 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -94.09 |
| Operating Margin | -96.61 |
AD
Management Effectiveness
| Return On Assets | -1.17 |
| Return On Equity | -1.56 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0.03 |
| Gross Profit | 0 |
| EBITDA | -26.97M |
| Net Income | -26.97M |
| Diluted EPS | -2.98 |
Balance Sheet
| Total Cash | 24.94M |
| Total Cash/Share | 2.43 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 8.57 |
| Book Value Per Share | 2.24 |
Price History
| 52-Week Change | -72.22 |
| 52-Week High | 10.89 |
| 52-Week Low | 2.13 |
| Moving Average 50 Days | 3.06 |
| Moving Average 200 Days | 4.88 |
Statistics
| Average Volume | 5.71M |
| Shares Outstanding | 9.26M |
| % Held by Institutions | 19.11 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:3 |
| Last Split Date | August 17, 2023 |
AD
